Press release
Global Enoxaparin API Market Report: Innovations and Regional Analysis for 2024-2030 | Valuates Reports
Enoxaparin API Market SizeThe global market for Enoxaparin API was estimated to be worth US$ 670 million in 2023 and is forecast to a readjusted size of US$ 1001.5 million by 2030 with a CAGR of 5.9% during the forecast period 2024-2030.
North American market for Enoxaparin API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-9M12983/Global_Enoxaparin_API_Industry_Research_Report_Growth_Trends_and_Competitive_Analysis_2022_2028
Asia-Pacific market for Enoxaparin API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Enoxaparin API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Enoxaparin API include Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc, Bristol Myer Squibb Company, Bohehringer Ingelheim, Eisai Inc., Teva Pharmaceutical Industries Ltd., Abbot India Limited, Novartis AG and ChemWerth, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
By Type
• Multi Vials
• Pre-Filled Syringes
By Application
• COVID-19
• Pulmonary Embolism
• Atrial Fibrillation
Key Companies
Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc, Bristol Myer Squibb Company, Bohehringer Ingelheim, Eisai Inc., Teva Pharmaceutical Industries Ltd., Abbot India Limited, Novartis AG, ChemWerth, Laboratorios Farmaceuticos ROVI SA, Gland Pharma Limited, Hanways Chempharma Co. Ltd, Changzhou Qianhong Biopharma, Shenzhen Hepalink Pharmaceutical Group
View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-9M12983/global-enoxaparin-api-industry
Please reach us at sales@valuates.com
Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Enoxaparin API Market Report: Innovations and Regional Analysis for 2024-2030 | Valuates Reports here
News-ID: 3756838 • Views: …
More Releases from Valuates Reports
AI-Powered Pathology Market Size, Revenue Share, Insights & Future Outlook
AI-Powered Pathology Market Size
The global market for AI-Powered Pathology was valued at US$ 184 million in the year 2023 and is projected to reach a revised size of US$ 382 million by 2030, growing at a CAGR of 11.7% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-33C18563/Global_AI_Powered_Pathology_Market_Research_Report_2024?utm_source=openpr&utm_medium=referral
By Type
• Automated Image Analysis
• Disease Classification
• Predictive Modeling
By Application
• Hospital
• Diagnostic Centers
• Laboratories & Research Institutes
Key Companies
Indica Labs, Aignostics, Deep Bio, Mindpeak, Paige AI, DoMore Diagnostics, Visiopharm, Sonrai Analytics, Stratipath,…
AI In Clinical Trials Market Size, Revenue Share, Insights & Future Outlook
AI In Clinical Trials Market Size
The global market for AI In Clinical Trials was valued at US$ 52.3 million in the year 2024 and is projected to reach a revised size of US$ 82.4 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-29K15279/Global_AI_In_Clinical_Trials_Market_Research_Report_2023?utm_source=openpr&utm_medium=referral
By Type
• Software
• Service
By Application
• Pharmaceutical and Biotechnology Companies
• Contract Research Organization
Key Companies
Intel, The International Business Machines Corporation(IBM), Koninklijke Philips N.V., ConcertAl, Saama Technologies LLC,…
Forensic Accounting Services Market Size, Revenue Share, Insights & Future Outlo …
Forensic Accounting Services Market
The global Forensic Accounting Services market was valued at US$ 19930 million in 2022 and is anticipated to reach US$ 31160 million by 2029, witnessing a CAGR of 7.7% during the forecast period 2023-2029.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-1E9323/Global_Forensic_Accounting_Services_Market_Size_Status_and_Forecast_2022?utm_source=openpr&utm_medium=referral
In general, forensic accounting services entail using the specialized expertise and investigative abilities that CPAs possess to gather, examine, and assess the evidence as well as to interpret and convey conclusions…
Dental Anesthesia Market Size, Revenue Share, Insights & Future Outlook
Dental Anesthesia Market
The global market for Dental Anesthesia was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-8V13175/Global_Dental_Anesthesia_Market_Research_Report_2023?utm_source=Openpr&utm_medium=Referral
By Type
• Articaine
• Lidocaine
• Mepivacaine
• Bupivacaine
• Prilocaine
• Others
By Application
• Carpool/Cartridges
• Ampoules
• Vials
Key Companies
Laboratorios Inibsa, Pierre Pharma, Septodont, Laboratorios Normon, Primex Pharmaceuticals, ASPEN Group, 3M Company, Dentsply, Fresenius-Kabi
The Dental Anesthesia Market is experiencing steady market growth as dental care…
More Releases for Enoxaparin
Enoxaparin API Market Demand Driven by Healthcare Needs | Persistence Market Res …
✅ Market Overview: Trends, Statistics, and Growth Drivers
The Enoxaparin API market has gained substantial momentum in recent years, largely fueled by a surge in global demand for anticoagulant therapies. Enoxaparin, a low molecular weight heparin (LMWH), is widely used in the treatment of thrombotic conditions such as deep vein thrombosis (DVT), pulmonary embolism, and acute coronary syndromes. Its inclusion in the World Health Organization's list of essential medicines underlines…
Comprehensive Report on an Enoxaparin Manufacturing Plant Project: Cost and Reve …
Setting up an enoxaparin manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Enoxaparin Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing an enoxaparin manufacturing plant, covering…
Enoxaparin Sodium APIs and Preparations Market 2024-2030: Global Trends, Key Ins …
Enoxaparin Sodium APIs and Preparations - Market Size
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.
This report aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium APIs and Preparations, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Enoxaparin Sodium APIs and Preparations…
Enoxaparin Sodium Market : Size, Share, Growth, Analysis, Key Players, Revenue, …
Enoxaparin Sodium Market Size
The global Enoxaparin Sodium market was valued at US$ 3315 million in 2023 and is anticipated to reach US$ 5415 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-6L9458/Global_Enoxaparin_Sodium_Market_Insights_and_Forecast_to_2028
Enoxaparin Sodium Market
Enoxaparin sodium is an anticoagulant medication (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of…
Enoxaparin Sodium Market Revenue, Insights, Overview, Outlook, Analysis | Valuat …
Enoxaparin Sodium Market
The global Enoxaparin Sodium market was valued at US$ 3044.5 million in 2022 and is anticipated to reach US$ 5354.7 million by 2029, witnessing a CAGR of 8.3% during the forecast period 2023-2029.
Get Free Research Report: https://reports.valuates.com/request/sample/QYRE-Auto-6L9458/Global_Enoxaparin_Sodium_Market_Insights_and_Forecast_to_2028
Enoxaparin Sodium Market Share
Europe is the largest market of Enoxaparin Sodium, with about 60% market share, followed by North America with about 17% market share. Currently, there are many players in…
Advancements in Enoxaparin: An Overview of Latest Developments and Trends
The global 𝗘𝗻𝗼𝘅𝗮𝗽𝗮𝗿𝗶𝗻 market is estimated to attain a valuation of by the end of 2031, states a study by Transparency Market Research (TMR).
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the Enoxaparin industry. The current and historical status of the market together with forecasted market size and trends are demonstrated in the assessment in…
